Tag: #Global Trends

Key Development California-based biotechnology innovator ALZpath has formalized a comprehensive global licensing agreement with Abbott Laboratories to advance blood-based diagnostic... Read more

Key Development A U.S. Federal Judge has officially dismissed global biopharmaceutical giant Pfizer from a sweeping multi-state antitrust lawsuit accusing... Read more

Key Development Global biopharmaceutical leader Eli Lilly has entered into a new strategic research collaboration with Abbisko Therapeutics to drive... Read more

Biopharmaceutical pioneer Gilead Sciences, Inc. announced that the European Commission (EC) has formally granted marketing authorization for its flagship oncology... Read more

Global science and technology leader Merck has finalized a strategic research-stage collaboration with premier venture capital firm Versant Ventures to... Read more

A Missouri appeals court has formally declined to transfer Abbott Laboratories’ appeal of a landmark $495 million product liability verdict... Read more

Multinational pharmaceutical leader Eli Lilly and Co. announced that it anticipates launching its highly anticipated oral weight-loss pill within Europe... Read more

A closely watched experimental oncology drug positioned by Pfizer Inc. as a cornerstone of its future revenue portfolio has failed... Read more

Biopharmaceutical leader AbbVie has announced that the European Commission (EC) has formally granted marketing authorization expanding the indication for its... Read more